The mechanisms of chronicity in hepatitis C virus infection

Gastroenterology

Volumn 115, Issue 4, 1998, Pages 1015-1018

  Chang, K M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN;

CHRONIC HEPATITIS; CHRONICITY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HUMAN; MUTATION; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

EID: 0031710120     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70277-X     Document Type: Editorial

References (32)

1. MJ Alter HS Margolis K Krawczynski FN Judson A Mares WJ Alexander PY Hu JK Miller MA Gerber RE Sampliner The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic Non-A, non-B Hepatitis Study Team [see comments] N Engl J Med 1899 327
2. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359
3. HJ Alter To C or not to C: these are the questions Blood 85 1995 1681
4. GQ Kuo L Choo HJ Alter GL Gitnick AG Redeker RH Purcell T Miyamura JL Dienstag MJ Alter CE Stevens An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 244 1989 362
5. MJ Koziel D Dudley JT Wong J Dienstag M Houghton R Ralston BD Walker Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis [published erratum appears in J Immunol 1993;15;150:2563] J Immunol 149 1992 3339
6. A Cerny JG McHutchison C Pasquinelli MF Brown MA Brothers B Grabscheid P Fowler M Houghton FV Chisari Cytotoxic T lymphocyte response to hepatitis C virus–derived peptides containing the HLA A2.1 binding motif J Clin Invest 95 1995 521
7. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection Hepatology 21 1995 632
8. A Weiner AL Erickson J Kansopon K Crawford E Muchmore AL Hughes M Houghton CM Walker Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant Proc Natl Acad Sci U S A 92 1995 2755
9. KM Chang B Rehermann JG McHutchison C Pasquinelli S Southwood A Seite FV Chisari Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J Clin Invest 100 1997 2376
10. B Rebermann KM Chang JG McHutchison R Kokka M Houghton FV Chisari Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection J Clin Invest 98 1996 1432
11. P Farci J Bukh RH Purcell The quasispecies of hepatitis C virus and the host immune response Springer Semin Immunopathol 19 1997 5
12. SL Tsai YM Chen MH Chen CY Huang IS Sheen LI Yeh JH Huang GC Kuo YF Liaw Hepatitis C virus variants circumventing cytotoxic T-lymphocyte activity as a mechanism of chronicity Gastroenterology 115 1998 954 966
13. G Pantaleo AS Fauci New concepts in the immunopathogenesis of HIV infection Annu Rev Immunol 13 1995 487
14. H Hengel UH Koszinowski Interference with antigen processing by viruses [see comments] Curr Opin Immunol 9 1997 470
15. GL Smith Virus proteins that bind cytokines, chemokines or interferons Curr Opin Immunol 8 1996 467
16. D Moskophidir F Lechner H Pircher RM Zinkernagel Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells [published erratum appears in Nature 1993;15;364:262] [see comments] Nature 362 1993 758
17. P Borrow H Lewicki X Wei MS Horwitz N Peffer H Meyers JA Nelson JE Gairin BH Hahn MB Oldstone GM Shaw Antiviral pressure exerted by HIV-1–specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [see comments] Nat Med 3 1997 205
18. P Klenerman S Rowland-Jones S McAdam J Edwards S Daenke D Lalloo B Koppe W Rosenberg D Boyd A Edwards P Giangrande RE Phillips AJ McMichael Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants [see comments] Nature 369 1994 403
19. A Bertoletti A Sette FV Chisari A Penna M Levrero M De Carli F Fiaccadori C Ferrari Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells [see comments] Nature 369 1994 407
20. RE Lanford D Chavez FV Chisari C Sureau Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mono-nuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR J Virol 69 1995 8079
21. N Zhu A Khoshnan KA Schneider R Matsumoto G Dennert C Ware MM Lai Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis J Virol 74 1998 3691
22. G Ballardini P Groff P Pontisso F Giostra R Francesconi M Lenzi D Zauli A Alberti FB Bianchi Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C J Clin Invest 95 1995 2067
23. K Nouri-Aria TR Sallie M Mizokami BC Portmann R Williams Intrahepatic expression of hepatitis C virus antigens in chronic liver disease J Pathol 175 1995 77
24. B Rehermann KM Chang J McHutchinson R Kokka M Houghton CM Rice PV Chisari Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients J Virol 70 1996 7092
25. GL Davis LA Balart ER Schiff K Lindsay HC Bodenheimer Jr RP Perrillo W Carey JM Jacobson J Payne JL Dienstag DH VanTheil C Tamburto J Lefkowitch J Albrecht C Meschievitz TJ Ortego A Gibas Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial Hepatitis Interventional Therapy Group N Engl J Med 321 1989 1501 1505
26. AM Di Bisceglie P Martin C Kassianides M Lisker-Melman L Murray J Waggoner Z Goodman SM Banks JH Hoofnagle Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial N Engl J Med 321 1989 1506
27. N Enomoto J Sakuma Y Asahina M Kurosaki T Murakami C Yamamoto Y Ogura N Izumi F Marumo C Sato Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection N Engl J Med 334 1996 77
28. WT Hofgartner PS Sullivan DG Carithers DR Gretch Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b J Med Virol 53 1997 118
29. JM Pawlotsky GG Neumann AU Pellerin M Frainais D Dhumeaux Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations J Virol 72 1998 2795
30. MJ Gale Jr MJ Korth NM Tang SL Tan DA Hopkins TE Dever SJ Polyak DR Gretch MG Katze Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein Virology 230 1997 217
31. AJ Weiner HM Geysen C Christopherson JE Hall TJ Mason G Saracco F Bonino K Crawford CD Marion KA Crawford M Brunetto PJ Barr T Miyamura JG McHutchison M Houghton Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections Proc Natl Acad Sci U S A 89 1992 3468
32. T Kaneko T Moriyama K Udaka K Hiroishi H Kita H Okamoto H Yagita R Okumura M Imawari Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope Eur J Immunol 27 1997 1782